Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

GLP-1 drugs like Ozempic show promise in addiction treatment, with ongoing research and clinical trials redefining recovery approaches.
2024 brings insulin price cuts but analysis shows 775 med price hikes, including diabetes drugs. Future price negotiations and affordability resources highlighted
Explore strategies for managing post-meal blood sugar spikes in diabetes, including adjusting insulin doses, dietary changes, and physical activity. Learn the importance...
New study in Diabetes, Obesity and Metabolism reveals Brenzavvy, an affordable SGLT-2 inhibitor for type 2 diabetes, is heart-safe and effective. It lowers blood sugar...
The FDA is investigating reports of suicidal thoughts or actions in people taking diabetes and weight loss medications like Ozempic, Wegovy, and Mounjaro. Research is...
LillyDirect, a new telehealth platform and online pharmacy, aims to improve access to resources and medication for people living with diabetes, obesity, and migraines.
The FDA is investigating the sale of counterfeit Ozempic. Here’s how to check that your Ozempic is real.
Vertex pauses VX-880 trial after two deaths; fate of diabetes treatment uncertain as current participants continue therapy.
Discover diaTribe's best 2023 diabetes articles on new treatments, advances in technology, lifestyle tips, and groundbreaking insights for better diabetes management.
Study shows AI chatbot enhances insulin dosing for type 2 diabetes, improving glycemic control and reducing distress, marking a new era in diabetes management.
Explore the risks and precautions for diabetics using supplements like Vitamin E, St. John's Wort, Ginseng, Niacin, and Chromium, which can affect blood sugar levels and...
Cannabis use in people with type 1 diabetes can raise DKA risk and trigger a condition with similar symptoms called HK-CHS. Monitoring glucose, understanding effects,...
Starting on metformin? My journey with type 2 diabetes on learning how to deal with side effects, “faux lows,” and learning more about this therapy.
This article details Mounjaro's efficacy in type 2 diabetes management, highlighting the drug’s ability to significantly reduce A1C and body weight. Read about the...
Discover advancements in diabetic macular edema treatment options, including anti-VEGF therapies and non-invasive drugs, for better management of this vision-threatening...
Led by Dr. Jeremy Pettus, researchers at UC San Diego are investigating liver-targeted insulin in type 1 diabetes. Explore how this novel insulin could significantly...
People with diabetes are at higher risk for health issues like chronic kidney disease, diabetic macular edema, and liver disease. Here are clinical trials studying ways...
Orforglipron, Eli Lilly's once-daily oral GLP-1 receptor agonist, is being studied in ongoing clinical trials for obesity and type 2 diabetes. Data shows A1C reductions...
Advances in blood glucose management, weight loss, and heart health are at the forefront of type 2 diabetes research. Here are some exciting new clinical trials you can...
The FINE-ONE trial by Bayer investigates Kerendia's effectiveness in preventing kidney disease progression in people with type 1 diabetes. This pivotal trial could...

Pages